310
Participants
Start Date
October 1, 2020
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2025
Nicotinamide treatment
Nicotinamide (500 mg) will be mixed in 50 ml of 0.9% saline and administered intravenously every 12 h for a total of 72 h.
placebo treatment
For the placebo group, an identical volume of 0.9% saline will be administered in the same manner.
CHU Amiens, Amiens
Centre Hospitalier de Dieppe
UNKNOWN
Centre Hospitalier d'Abbeville
OTHER
Centre Hospitalier de Laon
UNKNOWN
University Hospital, Caen
OTHER
Centre Hospitalier de Cherbourg
UNKNOWN
University Hospital, Rouen
OTHER
Centre Hospitalier de Roubaix
OTHER
Centre Hospitalier de Bethune
NETWORK
Hôpital Saint Philibert, Lomme
UNKNOWN
Tourcoing Hospital
OTHER
Centre Hospitalier de Valenciennes
NETWORK
Centre Hospitalier Arras
OTHER
Centre Hospitalier de Lens
OTHER
Centre Hospitalier de Calais
UNKNOWN
Centre Hospitalier Universitaire, Amiens
OTHER